Search | IOVS | ARVO Journals

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis.

Eric G Romanowski; Sonya M Mumper; Hazel Q Shanks; Kathleen A Yates; Jonathan B Mandell; Michael E Zegans; Robert M Q Shanks

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2095.

ARVO Annual Meeting Abstract June 2021

Are COVID-19 Antivirals Active against Adenovirus?

Eric G Romanowski; Kathleen A Yates; John Eric Romanowski; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):411.

ARVO Annual Meeting Abstract June 2020

The Disinfection of Bacterial, Fungal, and Viral Contaminated Contact Lenses and Cases with Hypochlorous Acid

Eric G Romanowski; Kathleen A Yates; John E Romanowski; Alex Mammen; Deepinder K Dhaliwal; Vishal Jhanji; Robert M Q Shanks; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):413.

ARVO Annual Meeting Abstract July 2019

Different Concentrations of Topical Fortified Vancomycin Produce Differences in Antibacterial Efficacy in an Experimental Model of MRSA Keratitis

Eric G Romanowski; John Romanowski; Kathleen A Yates; Alex Mammen; Deepinder K Dhaliwal; Vishal Jhanji; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):835.

ARVO Annual Meeting Abstract July 2018

Topical Penicillin Treatment of Staphylococcus aureus with Elevated MICs to Penicillin in a Rabbit Keratitis Model

Regis P Kowalski; Eric G Romanowski; Kathleen A Yates; John Eric Romanowski; Arman Grewal; Richard Anthony Bilonick

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2660.

ARVO Annual Meeting Abstract July 2018

The Successful Treatment of Experimental Methicillin-Resistant Staphylococcus aureus (MRSA) Keratitis with a Topical β-Lactam Antibiotic

John Eric Romanowski; Eric G Romanowski; Kathleen A Yates; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3658.

ARVO Annual Meeting Abstract June 2017

OKG-0301, a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Model.

Eric G Romanowski; Kathleen A Yates; Robert M Q Shanks; John E Romanowski; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3614.

ARVO Annual Meeting Abstract June 2017

Evaulation of predatory bacteria on corneal wound healing, ocular safety, and clearance of fluoroquinolone resistant Pseudomonas aeruginosa from the ocular surface

Robert M Q Shanks; Eric G Romanowski; Kimberly Brothers; Kathleen A Yates; Shilpi Gupta; Sonal Dharani; Daniel E Kadouri

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4291.

ARVO Annual Meeting Abstract September 2016

Is Benzalkonium Chloride (BAK) an Effective Antiviral against Adenovirus?

Eric G Romanowski; Kathleen A Yates; Robert M Q Shanks; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2337.

ARVO Annual Meeting Abstract June 2015

The Evaluation of Topical SPL, a Novel Dendrimer Antiviral, against Adenovirus in NZW Rabbit Ocular Models

Eric G Romanowski; Kathleen A Yates; Robert M Q Shanks; Oliver K Bernhard; Jeremy RA Paull; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1872.

ARVO Annual Meeting Abstract April 2014

The In Vitro Evaluation of the Virucidal Efficacy of Povidone-Iodine against Multiple Ocular Adenoviral Types

Eric G Romanowski; Katherine E Oconnor; Kathleen A Yates; Robert M Q Shanks; Regis P Kowalski

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2853.

ARVO Annual Meeting Abstract March 2012

An Antimicrobial Peptide Can Enhance the Activity of a Fluoroquinolone in Reducing Colony Counts of Fluoroquinolone-Resistant MRSA in the NZW Rabbit Keratitis Model

Eric G. Romanowski; Kathleen A. Yates; Francis S. Mah; Y J. Gordon; Regis P. Kowalski

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6257.

ARVO Annual Meeting Abstract April 2011

Is Polyhexamethylene Biguanide (PHMB) an Effective Disinfectant for Adenovirus?

Eric G. Romanowski; Kathleen A. Yates; Katherine O'Connor; Francis S. Mah; Robert M. Shanks; Regis P. Kowalski

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5857.

Immunology and Microbiology November 2009

The In Vitro and In Vivo Evaluation of ddC as a Topical Antiviral for Ocular Adenovirus Infections

PDF

Eric G. Romanowski; Kathleen A. Yates; Y. Jerold Gordon
TAGS: adenovirus infections, antiviral agents, zalcitabine, cidofovir
Invest. Ophthalmol. Vis. Sci.. 2009; 50(11):5295-5299. https://doi.org/10.1167/iovs.08-3286

Immunology and Microbiology May 2006

N -Chlorotaurine Is an Effective Antiviral Agent against Adenovirus In Vitro and in the Ad5/NZW Rabbit Ocular Model

PDF

Eric G. Romanowski; Kathleen A. Yates; Barbara Teuchner; Markus Nagl; Eveline U. Irschick; Y. Jerold Gordon
TAGS: adenovirus infections, adenoviruses, antiviral agents, oryctolagus cuniculus, ammonium chloride
Invest. Ophthalmol. Vis. Sci.. 2006; 47(5):2021-2026. https://doi.org/10.1167/iovs.05-1270

Cornea October 2005

Adenovirus-Directed Ocular Innate Immunity: The Role of Conjunctival Defensin-like Chemokines (IP-10, I-TAC) and Phagocytic Human Defensin-α

PDF

Stephen A. K. Harvey; Eric G. Romanowski; Kathleen A. Yates; Y. Jerold Gordon
TAGS: adenovirus infections, adenoviruses, antiviral agents, chemokines, conjunctiva, defensins, genes, immunity, natural, infections, teller acuity cards
Invest. Ophthalmol. Vis. Sci.. 2005; 46(10):3657-3665. https://doi.org/10.1167/iovs.05-0438

Immunology and Microbiology July 2001

The Antiviral Resistance and Replication of Cidofovir-Resistant Adenovirus Variants in the New Zealand White Rabbit Ocular Model

PDF

Eric G. Romanowski; Y. Jerold Gordon; Trinita Araullo-Cruz; Kathleen A. Yates; Paul R. Kinchington
TAGS: adenoviruses, cidofovir, drug resistance, viral, new zealand, oryctolagus cuniculus, viruses
Invest. Ophthalmol. Vis. Sci.. 2001; 42(8):1812-1815.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis.

Are COVID-19 Antivirals Active against Adenovirus?

The Disinfection of Bacterial, Fungal, and Viral Contaminated Contact Lenses and Cases with Hypochlorous Acid

Different Concentrations of Topical Fortified Vancomycin Produce Differences in Antibacterial Efficacy in an Experimental Model of MRSA Keratitis

Topical Penicillin Treatment of Staphylococcus aureus with Elevated MICs to Penicillin in a Rabbit Keratitis Model

The Successful Treatment of Experimental Methicillin-Resistant Staphylococcus aureus (MRSA) Keratitis with a Topical β-Lactam Antibiotic

OKG-0301, a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Model.

Evaulation of predatory bacteria on corneal wound healing, ocular safety, and clearance of fluoroquinolone resistant Pseudomonas aeruginosa from the ocular surface

Is Benzalkonium Chloride (BAK) an Effective Antiviral against Adenovirus?

The Evaluation of Topical SPL, a Novel Dendrimer Antiviral, against Adenovirus in NZW Rabbit Ocular Models

The In Vitro Evaluation of the Virucidal Efficacy of Povidone-Iodine against Multiple Ocular Adenoviral Types

An Antimicrobial Peptide Can Enhance the Activity of a Fluoroquinolone in Reducing Colony Counts of Fluoroquinolone-Resistant MRSA in the NZW Rabbit Keratitis Model

Is Polyhexamethylene Biguanide (PHMB) an Effective Disinfectant for Adenovirus?

The In Vitro and In Vivo Evaluation of ddC as a Topical Antiviral for Ocular Adenovirus Infections

N -Chlorotaurine Is an Effective Antiviral Agent against Adenovirus In Vitro and in the Ad5/NZW Rabbit Ocular Model

Adenovirus-Directed Ocular Innate Immunity: The Role of Conjunctival Defensin-like Chemokines (IP-10, I-TAC) and Phagocytic Human Defensin-α

The Antiviral Resistance and Replication of Cidofovir-Resistant Adenovirus Variants in the New Zealand White Rabbit Ocular Model

To View More...

You must be signed into an individual account to use this feature.